|
COX7A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.317000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.401400E-01 |
| Normal-vs-Stage2 |
1.531210E-01 |
| Normal-vs-Stage3 |
3.134100E-02 |
| Normal-vs-Stage4 |
2.306800E-01 |
| Stage1-vs-Stage2 |
3.971800E-02 |
| Stage1-vs-Stage3 |
7.193700E-02 |
| Stage1-vs-Stage4 |
5.442600E-01 |
| Stage2-vs-Stage3 |
5.379700E-03 |
| Stage2-vs-Stage4 |
2.791900E-02 |
| Stage3-vs-Stage4 |
5.403200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.026400E-01 |
| Normal-vs-AfricanAmerican |
1.296670E-03 |
| Normal-vs-Asian |
7.006200E-01 |
| Caucasian-vs-AfricanAmerican |
7.801200E-03 |
| Caucasian-vs-Asian |
1.033190E-01 |
| AfricanAmerican-vs-Asian |
1.660640E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.744400E-01 |
| Normal-vs-Female |
3.013800E-01 |
| Male-vs-Female |
3.309200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.760010E-01 |
| Normal-vs-Age(41-60Yrs) |
4.432800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.779400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.266800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.463000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.503960E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.594200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.026600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.826200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.064200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.939600E-01 |
| Classical-VS-Follicular |
1.91545999999043E-05 |
| Classical-VS-Other |
9.689400E-01 |
| Classical-VS-Normal |
5.690000E-02 |
| Tall-VS-Follicular |
5.66410000000239E-05 |
| Tall-VS-Other |
6.262200E-01 |
| Tall-VS-Normal |
3.058400E-02 |
| Follicular-VS-Other |
2.284000E-02 |
| Follicular-VS-Normal |
1.384030E-02 |
| Other-VS-Normal |
4.173400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.158800E-01 |
| Normal-vs-N1 |
1.280170E-01 |
| N0-vs-N1 |
3.722100E-02 |
|
|
